371 results on '"Pak, Kyoungjune"'
Search Results
352. Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.
- Author
-
Im HJ, Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ, Chung JK, Kim EE, and Lee DS
- Subjects
- Female, Humans, Male, Predictive Value of Tests, Carcinoma, Non-Small-Cell Lung diagnostic imaging, Fluorodeoxyglucose F18, Lung Neoplasms diagnostic imaging, Positron-Emission Tomography, Radiopharmaceuticals
- Abstract
Purpose: We conducted a comprehensive systematic review of the literature on volumetric parameters from (18)F-FDG PET and a meta-analysis of the prognostic value of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) in patients with lung cancer., Methods: A systematic search of MEDLINE and EMBASE was performed using the keywords "positron emission tomography (PET)", "lung cancer", and "volume". Inclusion criteria were: (18)F-FDG PET used as an initial imaging tool; studies limited to non-small-cell lung cancer (NSCLC); volume measurement of lung cancer; patients who had not undergone surgery, chemotherapy, or radiotherapy before the PET scan; and studies that reported survival data. Event-free survival and overall survival were evaluated as outcomes. The impact of MTV and TLG on survival was measured in terms of the hazard ratio (HR) effect size. Data from each study were analysed using Review Manager 5.2., Results: Thirteen eligible studies including 1,581 patients were analysed. Patients with high MTV showed a worse prognosis with an HR of 2.71 (95% CI 1.82 - 4.02, p < 0.00001) for adverse events and an HR of 2.31 (95% CI 1.54 - 3.47, p < 0.00001) for death. Patients with high TLG also showed a worse prognosis with an HR of 2.35 (95% CI 1.91 - 2.89, p < 0.00001) for adverse events and an HR of 2.43 (95% CI 1.89 - 3.11, p < 0.00001) for death. The prognostic value of MTV and TLG remained significant in a subgroup analysis according to TNM stage as well as the methods for defining cut-off values and tumour delineation., Conclusion: Volumetric parameters from (18)F-FDG PET are significant prognostic factors for outcome in patients with NSCLC. Patients with a high MTV or TLG are at higher risk of adverse events and death. MTV and TLG were significant prognostic factors in patients with TNM stage I/II and stage III/IV NSCLC.
- Published
- 2015
- Full Text
- View/download PDF
353. Prognostic value of genetic mutations in thyroid cancer: a meta-analysis.
- Author
-
Pak K, Suh S, Kim SJ, and Kim IJ
- Subjects
- Carcinoma, Medullary genetics, Carcinoma, Papillary genetics, Humans, Prognosis, Mutation, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins c-ret genetics, Thyroid Neoplasms genetics, ras Proteins genetics
- Abstract
Background: Genetic mutations have been found to be associated with thyroid cancer. Previous studies have been focused on the relation between genetic mutations and thyroid cancer. We sought to evaluate the prognostic value of the three most common genetic mutations (BRAF, RAS, and RET) in patients with thyroid cancer., Methods: Sources from MEDLINE (inception to December 2013) and EMBASE (inception to December 2013) were searched. Studies of thyroid cancer with results of genetic mutations and studies that reported survival data were included and two authors performed the data extraction independently. Any discrepancies were resolved by a consensus., Results: Fourteen studies assessing BRAF mutations, 6 RAS mutations, 4 RET mutations, and 1 with analysis of both BRAF and RAS mutations were included in this meta-analysis. Patients with papillary thyroid cancer with BRAF mutations showed a 1.59-fold higher risk of events or a 2.66-fold higher risk of death than patients with papillary thyroid cancer without a BRAF mutation. Also, patients with RAS mutations showed a 2.90-fold higher risk of death by thyroid cancer than patients without a RAS mutation. In addition, patients with medullary thyroid cancer with RET mutations showed a 5.82-fold higher risk of death by the disease than without a RET mutation., Conclusions: Genetic mutations should be considered as a poor prognostic marker in thyroid cancer and may lead to better management of individual patients. However, the use of genetic mutations as prognostic markers should not be generalized, but individualized in the specific clinic setting.
- Published
- 2015
- Full Text
- View/download PDF
354. Prognostic value of SUVmean in oropharyngeal and hypopharyngeal cancers: comparison with SUVmax and other volumetric parameters of 18F-FDG PET.
- Author
-
Pak K, Cheon GJ, Kang KW, Chung JK, Kim EE, and Lee DS
- Subjects
- Adult, Aged, Disease-Free Survival, Female, Humans, Hypopharyngeal Neoplasms pathology, Lymphatic Metastasis diagnostic imaging, Male, Middle Aged, Multimodal Imaging, Oropharyngeal Neoplasms pathology, Prognosis, Retrospective Studies, Tomography, X-Ray Computed, Fluorodeoxyglucose F18, Hypopharyngeal Neoplasms diagnostic imaging, Oropharyngeal Neoplasms diagnostic imaging, Positron-Emission Tomography, Radiopharmaceuticals
- Abstract
Purpose: We investigated whether SUV parameters, from PET, can provide prognostic information for patients with oropharyngeal or hypopharyngeal cancer., Patients and Methods: Forty-eight patients with oropharyngeal or hypopharyngeal cancer who underwent PET before treatment were enrolled. A volume of interest was placed on PET images covering the entire tumor volume and metastatic lymph nodes, and the SUVmax, SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured., Results: With the use of Kaplan-Meier analysis, age, SUVmean, MTV, and TLG predicted decreased disease-free survival (DFS). However, SUVmax was not associated with DFS. In multivariate analysis, the variables were included in 3 separate models. An SUVmean2.5 was an independent prognostic factor for DFS. Other SUV parameters, such as MTV and TLG, were associated with trends toward a decreasing DFS., Conclusions: SUVmean of PET was an independent prognostic factor for DFS in patients with oropharyngeal and hypopharyngeal cancer.
- Published
- 2015
- Full Text
- View/download PDF
355. Additional Prognostic Value of SUVmax Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients.
- Author
-
Yun MS, Kim SJ, Pak K, and Lee CH
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers blood, Carbonic Anhydrase IX, Female, Fluorodeoxyglucose F18, Humans, Middle Aged, Multimodal Imaging methods, Neoplasm Recurrence, Local metabolism, Neoplasm Recurrence, Local prevention & control, Prognosis, Radiopharmaceuticals, Reproducibility of Results, Sensitivity and Specificity, Survival Rate, Uterine Cervical Neoplasms surgery, Antigens, Neoplasm blood, Carbonic Anhydrases blood, Neoplasm Recurrence, Local diagnosis, Positron-Emission Tomography methods, Tomography, X-Ray Computed methods, Uterine Cervical Neoplasms diagnosis, Uterine Cervical Neoplasms metabolism
- Abstract
Purpose: We compared the prognostic ability of the maximum standardized uptake value (SUVmax) and various biological marker expressions to predict recurrence in patients with surgically resected cervical cancer., Methods: A retrospective review identified 60 patients with cervical cancer who received [18F]fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) at the time of the diagnosis of cancer. The SUVmax, expressions of carbonic anhydrase-IX (CA-IX), glucose transporter 1 (GLUT-1), and vascular endothelial growth factor (VEGF), and known prognostic factors were investigated., Results: The median follow-up time was 22.2 months (range 3.4-43.1 months). Using univariate analyses, the stage (stage II, p = 0.0066), SUVmax (> 6, p = 0.027), parametrial involvement (p < 0.0001), and positivity for CA-IX (p = 0.0191) were associated with recurrences of cervical cancer. With the Cox proportional hazard regression model, the SUVmax was a potent predictor for disease-free survival (DFS)., Conclusion: Although CA-IX expression was related to DFS in the current study, the potent predictor for DFS was SUVmax. Therefore, SUVmax is of greater prognostic value than biological marker expression in patients with surgically resected cervical cancer., (© 2015 S. Karger GmbH, Freiburg.)
- Published
- 2015
- Full Text
- View/download PDF
356. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT.
- Author
-
Lee G, I H, Kim SJ, Jeong YJ, Kim IJ, Pak K, Park DY, and Kim GH
- Subjects
- Aged, Endosonography, Esophageal Neoplasms surgery, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasm Staging, Positron-Emission Tomography, Retrospective Studies, Tomography, X-Ray Computed, Diagnostic Imaging methods, Esophageal Neoplasms diagnosis, Esophageal Neoplasms pathology, Preoperative Period
- Abstract
Unlabelled: This was a study to compare the diagnostic efficacies of endoscopic ultrasonography (EUS), CT, PET/MR imaging, and PET/CT for the preoperative local and regional staging of esophageal cancer, with postoperative pathologic stage used as the reference standard., Methods: During 1 y, 19 patients with resectable esophageal cancer were enrolled and underwent preoperative EUS, CT, PET/CT, and PET/MR imaging. A chest radiologist and nuclear medicine physician retrospectively reviewed the images and assigned tumor and lymph node stages according to the seventh version of the TNM system and the American Joint Committee on Cancer staging system. Four patients who were treated nonsurgically were excluded from data analysis. The efficacies of EUS, CT, PET/CT, and PET/MR imaging were compared., Results: Primary tumors were correctly staged in 13 (86.7%), 10 (66.7%), and 5 (33.3%) patients at EUS, PET/MR imaging, and CT, respectively (P value ranging from 0.021 to 0.375). The accuracy of determining T1 lesions was 86.7%, 80.0%, and 46.7% for EUS, PET/MR imaging, and CT, respectively. For distinguishing T3 lesions, the accuracy was 93.3% for EUS and 86.7% for both PET/MR imaging and CT. For lymph node staging, the accuracy was 83.3%, 75.0%, 66.7%, and 50.0% for PET/MR imaging, EUS, PET/CT, and CT, respectively. In addition, area-under-the-curve values were 0.800, 0.700, 0.629, and 0.543 for PET/MR imaging, EUS, PET/CT, and CT, respectively., Conclusion: PET/MR imaging demonstrated acceptable accuracy for T staging compared with EUS and, although not statistically significant, even higher accuracy than EUS and PET/CT for prediction of N staging. With adjustments in protocols, PET/MR imaging may provide an important role in preoperative esophageal cancer staging in the future., (© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
357. Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis.
- Author
-
Pak K, Cheon GJ, Nam HY, Kim SJ, Kang KW, Chung JK, Kim EE, and Lee DS
- Subjects
- Disease-Free Survival, Head and Neck Neoplasms metabolism, Head and Neck Neoplasms pathology, Humans, Glycolysis, Head and Neck Neoplasms diagnosis, Tumor Burden
- Abstract
Unlabelled: We conducted a comprehensive systematic review of the literature on volumetric parameters and a meta-analysis of the prognostic value of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in patients with head and neck cancer (HNC)., Methods: A systematic search of MEDLINE and EMBASE was performed using the key words PET, head and neck, and volume. Inclusion criteria were (18)F-FDG PET used as an initial imaging tool; studies limited to HNC; patients who had not undergone surgery, chemotherapy, or radiotherapy before PET scans; and studies reporting survival data. Event-free survival and overall survival were considered markers of outcome. The impact of MTV or TLG on survival was measured by the effect size hazard ratio (HR). Data from each study were analyzed using Review Manager., Results: Thirteen studies comprising 1,180 patients were included in this study. The combined HR for adverse events was 3.06 (2.33-4.01, P < 0.00001) with MTV and 3.10 (2.27-4.24, P < 0.00001) with TLG, meaning that tumors with high volumetric parameters were associated with progression or recurrence. Regarding overall survival, the pooled HR was 3.51 (2.62-4.72, P < 0.00001) with MTV and 3.14 (2.24-4.40, P < 0.00001) with TLG. There was no evidence of significant statistical heterogeneity at an I(2) of 0%., Conclusion: MTV and TLG are prognostic predictors of outcome in patients with HNC. Despite clinically heterogeneous HNC and the various methods adopted between studies, we can confirm that patients with a high MTV or TLG have a higher risk of adverse events or death., (© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
358. The effectiveness of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal prior to radioiodine remnant ablation in thyroid cancer: a meta-analysis of randomized controlled trials.
- Author
-
Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ, Kim EE, Lee DS, and Chung JK
- Subjects
- Catheter Ablation, Clinical Trials as Topic, Databases, Factual, Humans, Recombinant Proteins biosynthesis, Recombinant Proteins genetics, Recombinant Proteins therapeutic use, Risk, Thyroglobulin analysis, Thyroglobulin metabolism, Thyroid Neoplasms diagnostic imaging, Thyrotropin genetics, Thyrotropin metabolism, Treatment Outcome, Ultrasonography, Whole Body Imaging, Iodine Radioisotopes therapeutic use, Radiopharmaceuticals therapeutic use, Thyroid Neoplasms drug therapy, Thyrotropin therapeutic use
- Abstract
We evaluated the efficacy of recombinant human thyroid-stimulating hormone (rhTSH) versus thyroid hormone withdrawal (THW) prior to radioiodine remnant ablation (RRA) in thyroid cancer. A systematic search of MEDLINE, EMBASE, the Cochrane Library, and SCOPUS was performed. Randomized controlled trials that compared ablation success between rhTSH and THW at 6 to 12 months following RRA were included in this study. Six trials with a total of 1,660 patients were included. When ablation success was defined as a thyroglobulin (Tg) cutoff of 1 ng/mL (risk ratio, 0.99; 95% confidence interval, 0.96-1.03) or a Tg cutoff of 1 ng/mL plus imaging modality (RR 0.97; 0.90-1.05), the results of rhTSH and THW were similar. There were no significant differences when ablation success was defined as a Tg cutoff of 2 ng/mL (RR 1.03; 0.95-1.11) or a Tg cutoff of 2 ng/mL plus imaging modality (RR 1.02; 0.95-1.09). When a negative (131)I-whole body scan was used solely as the definition of ablation success, the effects of rhTSH and THW were not significantly different (RR 0.97; 0.93-1.02). Therefore, ablation success rates are comparable when RRA is prepared by either rhTSH or THW.
- Published
- 2014
- Full Text
- View/download PDF
359. Incidental thyroid cancer detected by (18)F-FDG PET: does it have different clinicopathological features?
- Author
-
Pak K, Cheon GJ, Lee KE, Park YJ, Choi HS, Min HS, Kang KW, Chung JK, Kim EE, and Lee DS
- Subjects
- Female, Humans, Male, Middle Aged, Fluorodeoxyglucose F18, Incidental Findings, Positron-Emission Tomography, Thyroid Neoplasms diagnostic imaging, Thyroid Neoplasms pathology
- Abstract
Objectives: The prevalence and risk of malignancy in thyroid incidentalomas has been investigated in previous studies; however, these studies have not looked at the characteristics of incidental thyroid cancer (ITC) detected by fluorine-18 fluorodeoxyglucose PET. Therefore, we aimed to assess the clinicopathologic features of ITC., Methods: From March 2008 to December 2011, a total of 2892 patients underwent total thyroidectomy for papillary thyroid cancer. Among them, patients belonging to the ITC group were defined as those in whom focal thyroid uptake was reported as an incidental finding on PET imaging and further evaluation revealed the presence of malignancy. In addition, two control groups with non-PET incidental thyroid cancer (NITC) were selected: NITC-A patients (n=48) who underwent a total thyroidectomy in March 2008 and NITC-B patients (n=48) who underwent a total thyroidectomy for papillary thyroid cancer and were matched for the confounding effects of age and sex., Results: There were no significant differences in clinicopathologic features, except for age and tumour node metastasis (TNM) staging, between ITC and NITC-A patients. More ITC than NITC-A patients were aged 45 years or older. Although T, N, or M staging was not different between ITC and NITC-A, there were more ITC patients with stage III/IV tumours. After matching for age and sex, none of the clinicopathologic features showed significant differences between ITC and NITC-B patients., Conclusion: No significant differences were observed between ITC and NITC patients except for age and TNM staging. More ITC patients had advanced TNM stage most likely due to patient age.
- Published
- 2014
- Full Text
- View/download PDF
360. The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
- Author
-
Pak K, Kim SJ, Kim IJ, Kim BH, Kim SS, and Jeon YK
- Subjects
- Humans, Positron-Emission Tomography, Thyroid Neoplasms surgery, Fluorodeoxyglucose F18, Radiopharmaceuticals, Thyroid Neoplasms diagnostic imaging
- Abstract
The incidence of thyroid cancer in both men and women is increasing faster than that of any other cancer. Although positron emission tomography (PET) using (18)F-fluorodeoxyglucose (FDG) has received much attention, the use of FDG PET for the management of thyroid cancer is limited primarily to postoperative follow-up. However, it might have a role in selected, more aggressive pathologies, and so patients at a high risk of distant metastasis may benefit from PET before surgery. As less FDG-avid thyroid cancers may lower the diagnostic accuracy of PET in preoperative assessment, an understanding of FDG avidity is important for the evaluation of thyroid cancer. FDG avidity has been shown to be associated with tumor size, lymph node metastasis, and glucose transporter expression and differentiation. As PET is commonly used in clinical practice, the detection of incidentalomas by PET is increasing. However, incidentalomas detected by PET have a high risk of malignancy. Clinicians handling cytologically indeterminate nodules face a dilemma regarding a procedure for a definitive diagnosis, usually lobectomy. With 'nondiagnostic (ND)' fine-needle biopsy (FNA), PET has shown a negative predictive value (NPV) of 100%, which indicates that negative uptake in a ND FNA procedure accurately excludes malignancy. With 'atypia of undetermined significance' or 'follicular neoplasm', the sensitivity and NPV of PET are 84 and 88%. PET does not provide additional information for the preoperative assessment of thyroid cancer. However, factors associated with FDG positivity are related to a poor prognosis; therefore, FDG PET scans before surgery may facilitate the prediction of the prognosis of differentiated thyroid cancer.
- Published
- 2013
- Full Text
- View/download PDF
361. Impact of cytokines on diffuse splenic 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomography.
- Author
-
Pak K, Kim SJ, Kim IJ, Kim DU, Kim K, and Kim H
- Subjects
- Aged, Biological Transport, Female, Hematologic Tests, Humans, Liver diagnostic imaging, Liver metabolism, Male, Neoplasms blood, Neoplasms diagnostic imaging, Neoplasms metabolism, Cytokines blood, Fluorodeoxyglucose F18 metabolism, Multimodal Imaging, Positron-Emission Tomography, Spleen diagnostic imaging, Spleen metabolism, Tomography, X-Ray Computed
- Abstract
Objectives: Concurrent inflammation or anemia at the time of PET/computed tomography (CT) could be one of several causes of diffuse splenic (18)F-fluorodeoxyglucose ((18)F-FDG) uptake. In this study, we focused on cytokines to investigate interactions during this phenomenon and clarify the significance of splenic (18)F-FDG uptake in PET/CT., Methods: We selected 40 patients (17 women and 23 men) with cholangiocarcinoma, pancreatic cancer, or gallbladder cancer who had undergone PET/CT. These patients were subdivided into two groups (group A: patients showing splenic (18)F-FDG uptake exceeding hepatic uptake; group B: patients showing hepatic (18)F-FDG uptake exceeding splenic uptake). Blood sampling was performed for each patient on the same day as PET/CT, and 22 types of cytokines and hematologic indices were analyzed., Results: Group A showed higher levels of interleukin (IL)-1β (P=0.0478), IL-1RA (P=0.0044), IL-4 (P=0.0118), IL-6 (P=0.0375), IL-7 (P=0.0478), and IL-13 (P=0.0081) compared with group B. However, interferon-inducible protein-10 (IP-10; P=0.1714), IL-9 (P=0.8022), IL-8 (P=0.1631), IL-5 (P=0.5273), IL-3 (P=0.3097), IL-23 (P=0.1194), IL-2 (P=0.1099), IL-1α (P=0.4439), IL-17α (P=0.8811), IL-16 (P=0.3201), IL-15 (P=0.0580), interferon-γ (IFN-γ; P=0.5308), growth-regulated oncogene (GRO; P=0.2847), granulocyte macrophage-colony-stimulating factor (GM-CSF; P=0.0913), granulocyte-colony-stimulating factor (G-CSF; P=0.5244), and soluble CD40 ligand (sCD40L; P=0.1714) levels in group A were not statistically significantly different compared with those in the control group. In addition, the white blood cell counts and C-reactive protein levels in group A showed higher values compared with group B. IL-13 among the cytokines and C-reactive protein among the hematologic indices were significant predictors of splenic (18)F-FDG uptake exceeding hepatic (18)F-FDG uptake., Conclusion: This study showed that splenic F-FDG uptake is related to IL-1β, IL-1receptor antagonist, IL-4, IL-6, IL-7, and IL-13. These cytokines may reflect the activation of humoral immunity of the spleen.
- Published
- 2013
- Full Text
- View/download PDF
362. Quantification of Tc-99m-ethyl cysteinate dimer brain single photon emission computed tomography images using statistical probabilistic brain atlas in depressive end-stage renal disease patients: Correlation with disease severity and symptom factors.
- Author
-
Kim H, Kim IJ, Kim SJ, Song SH, Pak K, and Kim K
- Abstract
This study adapted a statistical probabilistic anatomical map of the brain for single photon emission computed tomography images of depressive end-stage renal disease patients. This research aimed to investigate the relationship between symptom clusters, disease severity, and cerebral blood flow. Twenty-seven patients (16 males, 11 females) with stages 4 and 5 end-stage renal disease were enrolled, along with 25 healthy controls. All patients underwent depressive mood assessment and brain single photon emission computed tomography. The statistical probabilistic anatomical map images were used to calculate the brain single photon emission computed tomography counts. Asymmetric index was acquired and Pearson correlation analysis was performed to analyze the correlation between symptom factors, severity, and regional cerebral blood flow. The depression factors of the Hamilton Depression Rating Scale showed a negative correlation with cerebral blood flow in the left amygdale. The insomnia factor showed negative correlations with cerebral blood flow in the left amygdala, right superior frontal gyrus, right middle frontal gyrus, and left middle frontal gyrus. The anxiety factor showed a positive correlation with cerebral glucose metabolism in the cerebellar vermis and a negative correlation with cerebral glucose metabolism in the left globus pallidus, right inferior frontal gyrus, both temporal poles, and left parahippocampus. The overall depression severity (total scores of Hamilton Depression Rating Scale) was negatively correlated with the statistical probabilistic anatomical map results in the left amygdala and right inferior frontal gyrus. In conclusion, our results demonstrated that the disease severity and extent of cerebral blood flow quantified by a probabilistic brain atlas was related to various brain areas in terms of the overall severity and symptom factors in end-stage renal disease patients.
- Published
- 2012
- Full Text
- View/download PDF
363. Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer Screening.
- Author
-
Pak K, Kim SJ, Kim IJ, Kim K, Kim H, and Kim SJ
- Abstract
Purpose: We aimed to evaluate the relation between visceral fat volume and fluorodeoxyglucose (FDG) uptake of the liver measured by maximum or mean standardized uptake value., Methods: We retrospectively analyzed 96 consecutive records of positron emission tomography/computed tomography (PET/CT) performed for cancer screening between May 2011 and December 2011. Subjects were divided into 2 groups according to Hounsfield unit (HU) of the liver comparing with that of the spleen. The control group (20 women, 56 men) demonstrating HU of the liver equal or greater than that of the spleen included 76 patients, while the fatty liver group (2 women, 18 men) showing HU of the liver less than that of the spleen included 20 patients. We compared FDG uptake of the liver and visceral fat volume between two groups. We evaluated correlation of hepatic FDG uptake measured by maximum or mean standardized uptake value (SUV) with visceral fat volume and attenuation., Results: The fatty liver disease group showed higher aspartate aminotransferase (AST)of (24.42 ± 7.22, p = 0.012), alanine aminotransferase (ALT) of (25.16 ± 11.68, p = 0.001), body mass index (BMI) of (24.58 ± 3.29, p = 0.021), and visceral fat volume (3063.53 ± 1561.43, p = 0.011) than the control group. There were no statistically significant differences of mean standardized uptake value of the liver (liver SUVmean) (2.73 ± 0.19, p = 0.723), maximum standardized uptake value of the liver (liver SUVmax) (3.39 ± 0.53, p = 0.8248) and liver SUVmean/spleen SUVmean (1.13 ± 0.10, p = 0.081) between the two groups. Strong correlations were shown between liver SUVmean and BMI (r = 0.609, p < 0.001) and between liver SUVmean and visceral fat volume (r = 0.457, p < 0.001). Liver SUVmax was also strongly correlated with BMI (r = 0.622, p = 0.001) and visceral fat volume (r = 0.547, p < 0.001). There was no significant association of mean attenuation value of the liver (liver HUmean) with liver SUVmean (r = -0.003, p = 0.979) or liver SUVmax (r = -0.120, p = 0.244)., Conclusion: Hepatic FDG uptake quantified as SUVmean or SUVmax is not correlated with hepatic steatosis but with visceral fat volume in cancer screening.
- Published
- 2012
- Full Text
- View/download PDF
364. Prognostic value of metabolic volume measured by F-18 FDG PET-CT in patients with esophageal cancer.
- Author
-
I H, Kim K, Kim SJ, Kim IJ, Pak K, and Kim H
- Abstract
Purpose: The aim of this study was to evaluate the usefulness of the metabolic tumor volume (MTV) measured by F-18 Fluorodeoxyglucose positron emission tomography (FDG PET-CT) in predicting recurrence free survival (RFS) in patients with esophageal cancer., Methods: Forty-five patients with squamous cell carcinoma, who had undergone whole-body F-18 FDG PET-CT scans before surgical resection, were included in this study. All patients were treated with Ivor-Lewis esophagectomy. The MTV was quantified within the primary tumor using the 50% threshold of the maximum standardized uptake value (SUV
max ) of the FDG uptake areas. The cutoff value of MTV50 was determined through receiver-operating characteristic curve. The Kaplan Meier method was used to find out the relationship between RFS and MTV50 . Univariate analysis and multivariate proportional hazards regression analysis were applied to test the significance of volumetric parameter of F-18 FDG PET-CT and other conventional prognostic factors for the prediction of RFS., Results: Overall median follow up period was 17.87 months (range: 1.07-63.27 months). The median survival between treatment completion and recurrence was 15.5 months (range: 1.37-72.43 months). Recurrence was found in eight patients. On univariate analysis, MTV50 (P = 0.0032), N stage (P = 0.0004), American Joint Committee on Cancer stage (P = 0.0101), tumor location (P = 0.0054) and adjuvant treatment (P = 0.0373) were significant predictors of RFS. Multivariate analysis showed that the independent prognostic factors were MTV50 (P = 0.0465), N stage (P = 0.0303) and tumor location (P = 0.0270)., Conclusion: Volume based parameter of F-18 FDG PET-CT may have a role in providing prognostic information in esophageal cancer patients who received esophagectomy., (© 2012 Tianjin Lung Cancer Institute and Blackwell Publishing Asia Pty. Ltd.)- Published
- 2012
- Full Text
- View/download PDF
365. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
- Author
-
Kim K, Kim SJ, Kim IJ, Kim YS, Pak K, and Kim H
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung mortality, Carcinoma, Non-Small-Cell Lung surgery, Disease-Free Survival, Female, Fluorodeoxyglucose F18 pharmacokinetics, Humans, Lung Neoplasms mortality, Lung Neoplasms surgery, Male, Middle Aged, Multimodal Imaging methods, Positron-Emission Tomography, Prognosis, Radiopharmaceuticals pharmacokinetics, Retrospective Studies, Survival Rate, Tomography, X-Ray Computed, Carcinoma, Non-Small-Cell Lung diagnostic imaging, Carcinoma, Non-Small-Cell Lung pathology, Lung Neoplasms diagnostic imaging, Lung Neoplasms pathology, Tumor Burden
- Abstract
Objectives: The aim of this study was to evaluate the usefulness of the tumor burden as characterized by the metabolic tumor volume (MTV) and total lesion glycolysis (TLG) measured by F-18 fluoro-2-deoxyglucose (F-18 FDG) PET-computed tomography (CT) in predicting recurrence-free survival (RFS) and overall survival (OS) in surgically resected non-small-cell lung cancer (NSCLC) patients., Methods: We retrospectively reviewed 91 patients with pathologically documented stages I-IIIA NSCLC. MTV and TLG were obtained according to various thresholds of the standard uptake value (SUV) of primary tumor using preoperative F-18 FDG PET-CT. We used comparison receiver-operating characteristic curve analysis to test the statistical significance of the differences among the multiple volumetric parameters calculated by various SUV cutoff values. RFS and OS were evaluated with the Kaplan-Meier method and Cox regression analysis., Results: On comparison receiver-operating characteristic curve analysis, no significant difference was found among the volumetric parameters calculated using various thresholds of SUV. Regardless of the thresholds, patients with smaller MTV and lower TLG showed longer RFS and OS. MTV and TLG measured by F-18 FDG PET-CT were found to have better predictive performance than SUVmax for recurrence and death. According to multivariate analyses, MTV2.5 was revealed as a significant prognostic factor for RFS. Tumor size over 3 cm was selected as a significant prognostic indicator of OS., Conclusion: Volume-based parameters of F-18 FDG PET-CT may have a role in providing prognostic information in NSCLC patients who have received surgical treatment.
- Published
- 2012
- Full Text
- View/download PDF
366. Hepatic uptake of Tc-99m DPD on bone scintigraphy: the influence of the interval with gadolinium-containing contrast of MRI.
- Author
-
Pak K, Kim SJ, Kim IJ, and Suh KT
- Subjects
- Aged, Female, Humans, Male, Radionuclide Imaging, Spleen diagnostic imaging, Whole Body Imaging, Bone and Bones diagnostic imaging, Contrast Media, Diphosphonates pharmacokinetics, Gadolinium, Liver diagnostic imaging, Magnetic Resonance Imaging, Organotechnetium Compounds pharmacokinetics
- Abstract
Purpose: There are various etiologies, which can result in nonosseous, nonurologic uptake in bone scintigraphy. This study aimed to evaluate the influence of the interval between gadolinium (Gd)-containing contrast of MRI and Tc-99m DPD (Tc-99m 3,3-diphosphono-1,2-propanedicarboxylic acid) on bone scintigraphy., Materials and Methods: We retrospectively analyzed 1028 patients with bone scintigraphy performed between January 2010 and February 2011. All these 1028 patients had MRI contrast administration prior to bone scintigraphy. Fifty patients (8 women, 42 men) showed hepatic uptake on bone scintigraphy. The patients were subdivided into 2 groups (group A: MRI performed on the same day with bone scintigraphy, group B: MRI performed 1 or 2 days before bone scintigraphy)., Results: Among 1028 subjects, hepatic uptake in patients with MRI and bone scintigraphy on the same day was shown in 39 of the 585 bone scintigraphies (6.67%), while hepatic uptake with interval of 1 and 2 days was visualized in 8 of the 186 (4.30%) and 3 of the 87 (3.45%) subjects. No patients with interval more than 2 days showed hepatic uptake of bone scintigraphy., Conclusion: The interval between MRI with Gd-contrast and bone scintigraphy has an influence on hepatic uptake. Gd-containing contrast injection before bone scintigraphy within 2 days might affect the nonosseous uptake of Tc-99m DPD. At least 2 days of interval between MRI and bone scintigraphy might be needed to avoid hepatic uptake of bone scintigraphy.
- Published
- 2012
- Full Text
- View/download PDF
367. Clinical significance of diffuse hepatic visualization and thyroid bed uptake on post-ablative iodine-131 whole body scan in differentiated thyroid cancer.
- Author
-
Kim K, Kim SJ, Kim IJ, Kim YK, Kim BS, and Pak K
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Recurrence, Local diagnostic imaging, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Prognosis, Radionuclide Imaging, Radiotherapy, Adjuvant, Retrospective Studies, Risk Factors, Sex Factors, Thyroid Neoplasms pathology, Thyroid Neoplasms surgery, Young Adult, Iodine Radioisotopes pharmacokinetics, Liver diagnostic imaging, Liver metabolism, Thyroid Gland diagnostic imaging, Thyroid Gland metabolism, Thyroid Neoplasms radiotherapy, Whole Body Imaging
- Abstract
Background: The aim of this study was to investigate whether diffuse hepatic and thyroid bed uptake of (131)I on post-ablative whole body scans (PAWBS) of patients with differentiated thyroid cancer (DTC) have any relevance for clinical outcome and parameters., Patients and Methods: We retrospectively reviewed 838 patients with DTC, who were treated at Pusan National University Hospital from 2004 to 2009. Grades of hepatic and thyroid bed uptake on (131)I whole body scan were classified from 0 to 3 by visual assessment. Recurrence-free survival was evaluated with the Kaplan-Meier method and Cox regression analysis., Results: Male patients having tumors larger than 4 cm (p = 0.005), multiple tumor foci (p < 0.001), involved margins (p = 0.006), and a higher TNM stage (p < 0.001) were more likely to relapse. Thyroid bed grade (p < 0.001) and liver uptake grade (p = 0.002) were also revealed as significant prognostic factors. Intense thyroid bed uptake and faint hepatic activity were related to poor prognosis., Conclusions: We suggest that increased retention of (131)I in the thyroid bed and less visualization of liver on PAWBS mean poor prognosis. This would be related to the amount of remnant thyroid tissue and ineffective destruction of it., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF
368. Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis.
- Author
-
Kim K, Kim SJ, Kim IJ, Kim BS, Pak K, and Kim H
- Subjects
- Acute Disease, Adult, Aged, Aged, 80 and over, Bone Marrow diagnostic imaging, Chronic Disease, Diagnosis, Differential, Female, Fluorodeoxyglucose F18 pharmacokinetics, Humans, Liver diagnostic imaging, Lumbar Vertebrae diagnostic imaging, Male, Middle Aged, Radiopharmaceuticals pharmacokinetics, Retrospective Studies, Spleen chemistry, Spleen diagnostic imaging, Spondylitis etiology, Suppuration complications, Tuberculosis complications, Young Adult, Multimodal Imaging methods, Positron-Emission Tomography, Spondylitis diagnostic imaging, Tomography, X-Ray Computed, Tuberculosis diagnostic imaging
- Abstract
Objective: The aim of this study was to investigate whether diffuse increased splenic fluorodeoxyglucose (FDG) uptake may be an indirect sign of an acute pyogenic cause of infectious spondylitis (IS)., Methods: A retrospective review identified consecutive records of patients with IS who underwent F-18 FDG positron emission tomography-computed tomography scans between January 2007 and July 2008 and recruited 23 patients (57.8 ± 15.6 years, range: 20-81 years, eight men, 15 women) and their hematological laboratory data. The regions of interest were used to measure the maximum standardized uptake value (SUVmax) for the bone marrow (BM), liver, and spleen in each patient. We calculated the spleen/liver ratio (S/L ratio) by dividing the spleen SUVmax by liver SUVmax and the spleen/BM ratio (S/B ratio) by dividing spleen SUVmax by BM SUVmax as a parameter to assess the splenic FDG uptake., Results: The acute pyogenic cause of the IS group showed statistically significantly higher values of spleen SUVmax (median, 1.71 vs. 1.16, P=0.0108), S/L ratio (median, 1.08 vs. 0.88, P=0.0454), and S/B ratio (median, 1.30 vs. 0.94, P=0.0055) than the chronic tuberculous cause of the IS. The optimal cut-off values for the quantitative indices were spleen SUVmax>1.49, S/B ratio>0.957, and S/L ratio>0.889., Conclusion: On the basis of the results presented, this study demonstrated that some quantitative indices from F-18 FDG positron emission tomography/computed tomography images could be indirect signs of an acute pyogenic cause of the IS. Among the various quantitative indices, spleen SUVmax, S/B ratio, and S/L ratio were potent indicators for an acute pyogenic cause of the IS.
- Published
- 2011
- Full Text
- View/download PDF
369. Effect of dialysis on cerebral blood flow in depressive end-stage renal disease patients.
- Author
-
Nam HY, Song SH, Kim SJ, Kwak IS, Kim IJ, Lee SB, Lee DW, Kim BS, Pak K, Kim YK, and Yun HS
- Subjects
- Adult, Aged, Brain blood supply, Brain diagnostic imaging, Cysteine analogs & derivatives, Cysteine chemistry, Dimerization, Female, Humans, Kidney Failure, Chronic complications, Kidney Failure, Chronic diagnostic imaging, Male, Middle Aged, Organotechnetium Compounds chemistry, Tomography, Emission-Computed, Single-Photon, Treatment Outcome, Cerebrovascular Circulation, Depressive Disorder complications, Kidney Failure, Chronic physiopathology, Kidney Failure, Chronic therapy, Renal Dialysis
- Abstract
Objective: The aim of this study was to investigate regional cerebral blood flow (rCBF) changes of end-stage renal disease (ESRD) patients with depressive symptoms during dialysis., Methods: Fourteen patients with ESRD underwent Tc-99m ethylcysteinate dimer (Tc-99m ECD) brain single photon emission computed tomography (SPECT) and were evaluated the severity of depressive mood at pre-dialytic period and at least 6 months after dialysis initiation. rCBF was analyzed using statistical parametric mapping (SPM) in brain SPECT image. The responder was defined as a decrease of ≥25% in Hamilton Depression Rating Scale (HDRS) score from baseline HDRS score., Results: Pre-dialysis brain SPECT did not show any rCBF differences between responders and non-responders. The follow-up brain SPECT revealed a significant higher perfusion in left middle temporal gyrus of responder group when compared with non-responder (hemisphere coordinate X, Y, Z; -58, -2, -16, peak Z = 3.36, p = 0.046). In responder, a significant increase in rCBF was found in right parahippocampal gyrus (hemisphere coordinate X, Y, Z; 30, -40, -14, peak Z = 3.51, p = 0.043). In non-responder, there were significant decreases in rCBF in left superior frontal gyrus (hemisphere coordinate X, Y, Z; -22, 30, 42, peak Z = 3.86, p = 0.032) and right orbitofrontal cortex (hemisphere coordinate X, Y, Z; 10, 58, -6, peak Z = 3.81, p = 0.046)., Conclusion: The present findings showed the characteristic patterns of rCBF changes in depressive ESRD patients having maintenance dialysis. Further investigations in brain blood flow and glucose metabolism are needed to elucidate the effect of dialysis itself and the difference of according to dialysis modality in patients having depression and ESRD.
- Published
- 2011
- Full Text
- View/download PDF
370. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
- Author
-
Kim BS, Kim IJ, Kim SJ, Pak K, and Kim K
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung complications, Female, Humans, Lung Neoplasms complications, Male, Middle Aged, Pleural Effusion etiology, Prognosis, Radiopharmaceuticals, Reproducibility of Results, Sensitivity and Specificity, Subtraction Technique, Carcinoma, Non-Small-Cell Lung diagnosis, Fluorodeoxyglucose F18, Lung Neoplasms diagnosis, Pleural Effusion diagnosis, Tomography, X-Ray Computed methods
- Abstract
Background: The purpose of this study was to evaluate the accuracy of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) imaging in the detection of malignant pleural effusion and pleural metastasis in patients with non-small cell lung cancer (NSCLC)., Materials and Methods: We analyzed F-18 FDG PET/CT images of 33 lung cancer patients with pleural effusion. We used 2 categorical parameters to differentiate malignant from benign pleural effusion: i) quantitative parameters using maximum standardized uptake value (SUVmax of effusion and pleura, and the following ratios: lesion to aorta (L/Ao), to cerebellum (L/Cbl), to liver (L/Liv), to nonlesion (L/NL), and to primary lung cancer (L/Prim)) and ii) various parameters determined by PET and CT scans (uptake at the pleural region, Hounsfield unit, size, and morphology of any solid abnormality)., Results: Malignant pleural effusions showed significantly higher L/Prim values than benign pleural effusions. The presence of pleural abnormality on CT and pleural region uptake on PET images were found to be significantly more frequent in cases of malignant pleural disease. These parameters could differentiate malignant and benign pleural effusion according to receiver operating characteristic (ROC) analyses. There were no statistical differences between L/Prim, pleural abnormality on CT, and pleural region uptake on PET images. Abnormal pleural region uptake on PET images was the most accurate parameter identifying malignant pleural effusion by logistic regression analysis., Conclusions: Our results suggest that F-18 FDG PET/CT can be used as a reliable and noninvasive method for the differentiation of malignant and benign pleural disease in patients with NSCLC., (Copyright © 2011 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF
371. The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance.
- Author
-
Nam HY, Kim SJ, Kim IJ, Kim BS, Pak K, and Kim K
- Subjects
- Biological Transport, Bone Marrow metabolism, Diffusion, Female, Hematologic Tests, Humans, Male, Middle Aged, Neoplasms blood, Positron-Emission Tomography, Retrospective Studies, Tomography, X-Ray Computed, Fluorodeoxyglucose F18 metabolism, Neoplasms diagnosis, Neoplasms metabolism, Spleen metabolism
- Abstract
Objective: The purpose of this study was to investigate correlations between diffuse splenic FDG uptake and hematological and inflammatory parameters to clarify the significance of splenic FDG uptake on PET/CT images., Methods: We retrospectively analyzed the consecutive records of F-18 FDG PET/CT scans and selected 31 patients with diffuse splenic FDG uptake as patient group. A total of 25 patients who underwent F-18 FDG PET/CT scans for simple health checkup were enrolled as control group. ROIs were placed on the liver and spleen to measure maximal standardized uptake value (SUVmax). The spleen SUVmax was divided by the liver SUVmax to calculate the spleen/liver ratio. The correlations between the S/L ratio and various hematological parameters were evaluated., Results: The S/L ratio was positively correlated with serum C-reactive protein level, white blood cell count, and neutrophil count and negatively correlated with hemoglobin, hematocrit, and red blood cell count. Under multiple regression analysis, the Hb level and the C-reactive protein level were the significant predictors for diffuse splenic FDG uptake., Conclusion: In conclusion, our study suggests that concurrent inflammation or anemia at the time of PET/CT study could be one of various causes of diffuse splenic FDG uptake.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.